Shear NH - Search Results

1

Canadian consensus statement on the use of intravenous immunoglobulin therapy in dermatology.

Mydlarski PR, Ho V, Shear NH. Mydlarski PR, et al. Among authors: shear nh. J Cutan Med Surg. 2006 Sep-Oct;10(5):205-21. doi: 10.2310/7750.2006.00048. J Cutan Med Surg. 2006. PMID: 17234104

2

Screening for azathioprine toxicity: a pharmacoeconomic analysis based on a target case.

Tavadia SM, Mydlarski PR, Reis MD, Mittmann N, Pinkerton PH, Shear N, Sauder DN. Tavadia SM, et al. J Am Acad Dermatol. 2000 Apr;42(4):628-32. J Am Acad Dermatol. 2000. PMID: 10727309

3

Intravenous immunoglobulin: use in dermatology.

Mydlarski PR, Mittmann N, Shear NH. Mydlarski PR, et al. Among authors: shear nh. Skin Therapy Lett. 2004 May;9(5):1-6. Skin Therapy Lett. 2004. PMID: 15146260 Free article. Review.

4

Integrating biologic agents into management of moderate-to-severe psoriasis: a consensus of the Canadian Psoriasis Expert Panel. February 27, 2004.

Guenther L, Langley RG, Shear NH, Bissonnette R, Ho V, Lynde C, Murray E, Papp K, Poulin Y, Zip C. Guenther L, et al. Among authors: shear nh. J Cutan Med Surg. 2004 Sep-Oct;8(5):321-37. doi: 10.1007/s10227-005-0035-1. J Cutan Med Surg. 2004. PMID: 15868311

5

Strategies for optimizing treatment with efalizumab in moderate to severe psoriasis.

Papp KA, Ho V, Langley R, Lynde C, Poulin Y, Shear N, Toole J, Zip C. Papp KA, et al. J Cutan Med Surg. 2006;9 Suppl 1:26-32. doi: 10.1007/s10227-006-0104-0. J Cutan Med Surg. 2006. PMID: 16633859 Review.

6

Recommendations for incorporating biologicals into management of moderate to severe plaque psoriasis: individualized patient approaches.

Langley RG, Ho V, Lynde C, Papp KA, Poulin Y, Shear N, Toole J, Zip C. Langley RG, et al. J Cutan Med Surg. 2006;9 Suppl 1:18-25. doi: 10.1007/s10227-006-0103-1. J Cutan Med Surg. 2006. PMID: 16633860 Review.

7

Efalizumab, a reversible T-cell modulator for psoriasis.

Shear NH, Langley RG, Ho V. Shear NH, et al. J Cutan Med Surg. 2006;9 Suppl 1:4-9. doi: 10.1007/s10227-006-0101-3. J Cutan Med Surg. 2006. PMID: 16633862 Review.

8

Intravenous immunoglobulin use in patients with toxic epidermal necrolysis and Stevens-Johnson syndrome.

Mittmann N, Chan B, Knowles S, Cosentino L, Shear N. Mittmann N, et al. Am J Clin Dermatol. 2006;7(6):359-68. doi: 10.2165/00128071-200607060-00004. Am J Clin Dermatol. 2006. PMID: 17173470 Review.

9

Effect of intravenous immunoglobulin on prednisone dose in patients with pemphigus vulgaris.

Mittmann N, Chan B, Knowles S, Mydlarski PR, Cosentino L, Shear N. Mittmann N, et al. J Cutan Med Surg. 2006 Sep-Oct;10(5):222-7. doi: 10.2310/7750.2006.00053. J Cutan Med Surg. 2006. PMID: 17234105

10

Chan B, Hales B, Shear N, Ho V, Lynde C, Poulin Y, Mittmann N. Chan B, et al. J Cutan Med Surg. 2009 Jul-Aug;13(4):192-7. doi: 10.2310/7750.2009.08068. J Cutan Med Surg. 2009. PMID: 19706226

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

431 results

Search Page

Filters